Literature DB >> 15762882

Mycobacterium tuberculosis genome-wide screen exposes multiple CD8 T cell epitopes.

A S Hammond1, M R Klein, T Corrah, A Fox, A Jaye, K P McAdam, R H Brookes.   

Abstract

Mounting evidence suggests human leucocyte antigen (HLA) class I-restricted CD8(+) T cells play a role in protective immunity against tuberculosis yet relatively few epitopes specific for the causative organism, Mycobacterium tuberculosis, are reported. Here a total genome-wide screen of M. tuberculosis was used to identify putative HLA-B*3501 T cell epitopes. Of 479 predicted epitopes, 13 with the highest score were synthesized and used to restimulate lymphocytes from naturally exposed HLA-B*3501 healthy individuals in cultured and ex vivo enzyme-linked immunospot (ELISPOT) assays for interferon (IFN)-gamma. All 13 peptides elicited a response that varied considerably between individuals. For three peptides CD8(+) T cell lines were expanded and four of the 13 were recognized permissively through the HLA-B7 supertype family. Although further testing is required we show the genome-wide screen to be feasible for the identification of unknown mycobacterial antigens involved in immunity against natural infection. While the mechanisms of protective immunity against M. tuberculosis infection remain unclear, conventional class I-restricted CD8(+) T cell responses appear to be widespread throughout the genome.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15762882      PMCID: PMC1809330          DOI: 10.1111/j.1365-2249.2005.02751.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  37 in total

1.  Potent induction of focused Th1-type cellular and humoral immune responses by RTS,S/SBAS2, a recombinant Plasmodium falciparum malaria vaccine.

Authors:  A Lalvani; P Moris; G Voss; A A Pathan; K E Kester; R Brookes; E Lee; M Koutsoukos; M Plebanski; M Delchambre; K L Flanagan; C Carton; M Slaoui; C Van Hoecke; W R Ballou; A V Hill; J Cohen
Journal:  J Infect Dis       Date:  1999-11       Impact factor: 5.226

2.  Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP).

Authors:  M Bunce; C M O'Neill; M C Barnardo; P Krausa; M J Browning; P J Morris; K I Welsh
Journal:  Tissue Antigens       Date:  1995-11

3.  Optimization of a peptide-based protocol employing IL-7 for in vitro restimulation of human cytotoxic T lymphocyte precursors.

Authors:  A Lalvani; T Dong; G Ogg; A A Patham; H Newell; A V Hill; A J McMichael; S Rowland-Jones
Journal:  J Immunol Methods       Date:  1997-12-15       Impact factor: 2.303

4.  Specificity and degeneracy in peptide binding to HLA-B7-like class I molecules.

Authors:  J Sidney; S Southwood; M F del Guercio; H M Grey; R W Chesnut; R T Kubo; A Sette
Journal:  J Immunol       Date:  1996-10-15       Impact factor: 5.422

Review 5.  A model for developmentally acquired thymus-dependent tolerance to central and peripheral antigens.

Authors:  Y Modigliani; A Bandeira; A Coutinho
Journal:  Immunol Rev       Date:  1996-02       Impact factor: 12.988

6.  Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria.

Authors:  C F Ockenhouse; P F Sun; D E Lanar; B T Wellde; B T Hall; K Kester; J A Stoute; A Magill; U Krzych; L Farley; R A Wirtz; J C Sadoff; D C Kaslow; S Kumar; L W Church; J M Crutcher; B Wizel; S Hoffman; A Lalvani; A V Hill; J A Tine; K P Guito; C de Taisne; R Anders; W R Ballou
Journal:  J Infect Dis       Date:  1998-06       Impact factor: 5.226

7.  Fine tuning of peptide binding to HLA-B*3501 molecules by nonanchor residues.

Authors:  C Schönbach; M Ibe; H Shiga; Y Takamiya; K Miwa; K Nokihara; M Takiguchi
Journal:  J Immunol       Date:  1995-06-01       Impact factor: 5.422

8.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.

Authors:  S T Cole; R Brosch; J Parkhill; T Garnier; C Churcher; D Harris; S V Gordon; K Eiglmeier; S Gas; C E Barry; F Tekaia; K Badcock; D Basham; D Brown; T Chillingworth; R Connor; R Davies; K Devlin; T Feltwell; S Gentles; N Hamlin; S Holroyd; T Hornsby; K Jagels; A Krogh; J McLean; S Moule; L Murphy; K Oliver; J Osborne; M A Quail; M A Rajandream; J Rogers; S Rutter; K Seeger; J Skelton; R Squares; S Squares; J E Sulston; K Taylor; S Whitehead; B G Barrell
Journal:  Nature       Date:  1998-06-11       Impact factor: 49.962

9.  Down-regulation of CD1 on antigen-presenting cells by infection with Mycobacterium tuberculosis.

Authors:  S Stenger; K R Niazi; R L Modlin
Journal:  J Immunol       Date:  1998-10-01       Impact factor: 5.422

10.  An antimicrobial activity of cytolytic T cells mediated by granulysin.

Authors:  S Stenger; D A Hanson; R Teitelbaum; P Dewan; K R Niazi; C J Froelich; T Ganz; S Thoma-Uszynski; A Melián; C Bogdan; S A Porcelli; B R Bloom; A M Krensky; R L Modlin
Journal:  Science       Date:  1998-10-02       Impact factor: 47.728

View more
  14 in total

1.  High-affinity human leucocyte antigen class I binding variola-derived peptides induce CD4+ T cell responses more than 30 years post-vaccinia virus vaccination.

Authors:  M Wang; S T Tang; O Lund; M H Dziegiel; S Buus; M H Claesson
Journal:  Clin Exp Immunol       Date:  2009-03       Impact factor: 4.330

Review 2.  Antigens for CD4 and CD8 T cells in tuberculosis.

Authors:  Cecilia S Lindestam Arlehamn; David Lewinsohn; Alessandro Sette; Deborah Lewinsohn
Journal:  Cold Spring Harb Perspect Med       Date:  2014-05-22       Impact factor: 6.915

3.  Identification of MHC class II restricted T-cell-mediated reactivity against MHC class I binding Mycobacterium tuberculosis peptides.

Authors:  Mingjun Wang; Sheila T Tang; Anette Stryhn; Sune Justesen; Mette V Larsen; Morten H Dziegiel; David M Lewinsohn; Søren Buus; Ole Lund; Mogens H Claesson
Journal:  Immunology       Date:  2011-02-07       Impact factor: 7.397

Review 4.  Mycobacterium tuberculosis-specific CD8+ T cells and their role in immunity.

Authors:  Joshua S M Woodworth; Samuel M Behar
Journal:  Crit Rev Immunol       Date:  2006       Impact factor: 2.214

5.  Association of Chlamydia pneumoniae infection with HLA-B*35 in patients with coronary artery disease.

Authors:  Anil Palikhe; Marja-Liisa Lokki; Pekka Saikku; Maija Leinonen; Mika Paldanius; Mikko Seppänen; Ville Valtonen; Markku S Nieminen; Juha Sinisalo
Journal:  Clin Vaccine Immunol       Date:  2007-11-07

6.  Immunogenicity of novel DosR regulon-encoded candidate antigens of Mycobacterium tuberculosis in three high-burden populations in Africa.

Authors:  Gillian F Black; Bonnie A Thiel; Martin O Ota; Shreemanta K Parida; Richard Adegbola; W Henry Boom; Hazel M Dockrell; Kees L M C Franken; Annemiek H Friggen; Philip C Hill; Michel R Klein; Maeve K Lalor; Harriet Mayanja; Gary Schoolnik; Kim Stanley; Karin Weldingh; Stefan H E Kaufmann; Gerhard Walzl; Tom H M Ottenhoff
Journal:  Clin Vaccine Immunol       Date:  2009-06-24

7.  Identification of special AT-rich sequence binding protein 1 as a novel tumor antigen recognized by CD8+ T cells: implication for cancer immunotherapy.

Authors:  Mingjun Wang; Bingnan Yin; Satoko Matsueda; Lijuan Deng; Ying Li; Wei Zhao; Jia Zou; Qingtian Li; Christopher Loo; Rong-Fu Wang; Helen Y Wang
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

8.  Identification of prostate-specific G-protein coupled receptor as a tumor antigen recognized by CD8(+) T cells for cancer immunotherapy.

Authors:  Satoko Matsueda; Mingjun Wang; Jinsheng Weng; Ying Li; Bingnan Yin; Jia Zou; Qingtian Li; Wei Zhao; Weiyi Peng; Xavier Legras; Christopher Loo; Rong-Fu Wang; Helen Y Wang
Journal:  PLoS One       Date:  2012-09-20       Impact factor: 3.240

9.  Transient expansion of activated CD8(+) T cells characterizes tuberculosis-associated immune reconstitution inflammatory syndrome in patients with HIV: a case control study.

Authors:  Enrique Espinosa; Dámaris P Romero-Rodríguez; María-Teresa Cantoral-Díaz; Gustavo Reyes-Terán
Journal:  J Inflamm (Lond)       Date:  2013-05-20       Impact factor: 4.981

10.  Analysis of Mycobacterium tuberculosis-specific CD8 T-cells in patients with active tuberculosis and in individuals with latent infection.

Authors:  Nadia Caccamo; Giuliana Guggino; Serena Meraviglia; Giuseppe Gelsomino; Paola Di Carlo; Lucina Titone; Marialuisa Bocchino; Domenico Galati; Alessandro Matarese; Jan Nouta; Michel R Klein; Alfredo Salerno; Alessandro Sanduzzi; Francesco Dieli; Tom H M Ottenhoff
Journal:  PLoS One       Date:  2009-05-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.